跳至主要内容
临床试验/NCT04723459
NCT04723459Unknown不适用

Nano-Ivermectin Impregnated Masks Versus Ordinary Surgical Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff

South Valley University2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年1月23日最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
试验地点
2
主要终点
Number of persons in each group who Complain of any suspected Symptoms

研究概览

简要总结

Antiviral efficacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks

详细描述

Antiviral effecacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks this study is a trial for evaluation of adding a proved antiviral material to the mask and to compare between the protective value of this mask and the ordinary one.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • health care personells and family contact of confirmed COVID-19 cases.

排除标准

  • refusal of participate to use the masks.
  • pregnancy or lactation known hypersensitivity to ivermectin.

结局指标

主要结局

Number of persons in each group who Complain of any suspected Symptoms

时间窗: within 14 days after enrollement

( Fever, Myalgia ,Cough, Sore Throat, Diarrhea, Shortness of Breath)

次要结局

  • Number of persons in each group who are diagnosed as COVID-19 patients(within 21 days after enrollement)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zaky Aref

ass.professor

South Valley University

研究点 (2)

Loading locations...

相似试验